4 completed, 1 suspended. 3 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 2 | Completed 1, Suspended 1 |
Follow MBT-0206: new trials by email Literature Review of MBT-0206 trials Research Report on MBT-0206
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX EndoTAG-1, Gemcitabine - Metastatic Pancreas Cancer, Locally Advanced Pancreatic Cancer | Phase 3 | Completed | SynCore Biotechnology Co., Ltd. | 218 | 2018-10-16 | 2023-05-06 |
| A Trial Evaluating the Efficacy and Safety of EndoTAG®-1 in Combination With Paclitaxel and Gemcitabine Compared With Paclitaxel and Gemcitabine as First-line Therapy in Patients With Visceral Metastatic Triple-negative Breast Cancer EndoTAG-1, Paclitaxel, Gemcitabine Hydrochloride - Triple-Negative Breast Cancer | Phase 3 | Suspended | SynCore Biotechnology Co., Ltd. | 420 | 2016-11-23 | 2023-04-26 |
| Trial of Neoadjuvant EndoTAG-1 in Combination With Paclitaxel in HER2-negative Breast Cancer EndoTAG-1 - Breast Cancer | Phase 2 | Completed | Jules Bordet Institute | 18 | 2011-11-01 | 2013-06-17 |
| EndoTAG-1 in Triple Receptor Negative Breast Cancer Patients EndoTAG-1 + paclitaxel, EndoTAG-1, Paclitaxel - Breast Neoplasms | Phase 2 | Completed | MediGene | 143 | 2007-01-01 | 2012-01-05 |
| EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas Gemcitabine alone, EndoTAG-1 and Gemcitabine - Adenocarcinoma, Metastasis | Phase 2 | Completed | MediGene | 212 | 2005-09-01 | 2008-11-14 |
Breast Neoplasms (2) · Neoplasm Metastasis (2) · Pancreatic Neoplasms (2) · Adenocarcinoma (1) · Recurrence (1) · Triple Negative Breast Neoplasms (1)
MediGene (2) · SynCore Biotechnology Co., Ltd. (2) · Jules Bordet Institute (1)
Belgium (2) · France (2) · Hungary (2) · Taiwan (2) · Ukraine (2) · Czechia (1) · India (1) · Israel (1) · Poland (1) · Romania (1) · Russia (1) · South Korea (1) · United States (1)
Ahmad Awada, Dr. (1) · Li-Tzong Chen, M.D., Ph.D. (1) · Michail Ignatiadis, MD, PhD (1) · Tsu-Yi Chao, M.D., Ph.D. (1)